The Investor Database Every Biotech Raise Starts With


900+ verified US biotech VCs with direct partner emails, investment focus, check sizes, and deal stage.

Built for founders. Trusted by fundraising advisors.


Whether you're raising your seed or helping a portfolio company close a Series B, the right VC contacts are already waiting.

Stop building lists. Start closing rounds.

Every entry in BioxList is hand-curated so you know exactly who you're pitching before you write a single word.

Each VC profile includes :

  • 📧 Direct partner emails — no gatekeepers, no contact forms
  • 🎯 Investment focus — Therapeutics, MedTech, Digital Health, Diagnostics and more
  • 💰 Typical check size — from $250K to $10M+
  • 📊 Deal stage — Seed, Series A, B and beyond

The data your pitch deck deserves.

Find Your Next Investor With BioxList

A curated database of 900+ US Biotech Venture Capital firms investing across Therapeutics, MedTech, Diagnostics, Biotechnology, Life Sciences IT/AI, Digital Health, and AgriTech.

Venture Capital Website Biotech Sectors Investment Stages Location Contacts

FAQ

What makes your database unique?

  • Biotech-only focus: No noise from unrelated industries.
  • Deep investor profiles: Funding criteria and even which scientific milestones they prioritize.

Why get a biotech-specific database?

  • Save 100+ hours: Replace guesswork with a ready-to-pitch list of investors pre-filtered by your stage, therapy area, and capital needs.
  • Avoid mismatches: Know which VCs are actively deploying capital in your niche.
  • Boost credibility: Use insider data to craft pitches that resonate with investor priorities.

Who uses BioxList?

  • Biotech founders raising Seed to Series C rounds.
  • Business development teams at life sciences startups.
  • Consultants building investor pipelines for clients.

How to use your database?

Receive an Excel file to manually browse and filter investors by stage, investment focus, or ticket size, then export emails from the CSV file for instant outreach to VC decision-makers. No tech skills required.